Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEstrella Immunopharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q1 2024 | -$0.09 | $0 | |||
| 10/28/2024 | Q4 2023 | -$0.11 | $0 | |||
| 03/29/2024 | Q3 2023 | -$0.01 | $0 | |||
| 12/30/2023 | Q2 2023 | -$0.03 | $0 | |||
| 09/29/2023 | Q1 2023 | -$1.78 | $0 | |||
| 06/28/2023 | Q4 2022 | -$0.03 | $0 | |||
| 03/29/2023 | Q3 2022 | -$0.03 | $0 | |||
| 12/30/2022 | Q2 2022 | -$1.18 | $0 | |||
| 09/28/2022 | Q1 2022 | -$0.06 | $0 | |||
| 06/29/2022 | Q4 2021 | -$0.03 | $0 | |||
| 03/30/2022 | Q3 2021 | -$0.03 | $0 | |||
| 12/30/2021 | Q2 2021 | -$0.00 | $0 | |||
| 09/28/2021 | Q1 2021 | -$0.02 | $0 |
Estrella Immunopharma, Inc. Earnings: FAQ's
How can I listen to Estrella Immunopharma, Inc.'s earnings conference
call?
The conference call for Estrella Immunopharma, Inc.'s latest earnings report can be listened to online.
How can I read Estrella Immunopharma, Inc.'s conference call transcript?
The conference call transcript for Estrella Immunopharma, Inc.'s latest earnings report can be read online.
How much profit does Estrella Immunopharma, Inc. generate each year?
Estrella Immunopharma, Inc. (:ESLAW) has a recorded net income of $0. Estrella Immunopharma, Inc. has generated $-0.21 earnings per share over the last four quarters.
What is Estrella Immunopharma, Inc.'s price-to-earnings ratio?
Estrella Immunopharma, Inc. (:ESLAW) has a price-to-earnings ratio of -4.39 and price/earnings-to-growth ratio is -0.05.